文献速递关节外科骨肿瘤

近端股骨转移性骨病骨水泥与非骨水泥髋关节置换的股骨柄翻修与柄并发症累积发生率

What Is the Cumulative Incidence of Femoral Stem Revision and Stem Complication in Cemented and Uncemented Hip Arthroplasty for Proximal Femoral Metastatic Bone Disease?
PubMed 文献 · Clin Orthop Relat Res · 2025-06-10

六中心回顾性研究纳入2011年1月至2022年12月因近端股骨转移性骨病行初次髋关节置换337例,骨水泥组287例、非骨水泥组50例,因基线差异大未做组间比较,分别以死亡为竞争风险报告累积发生率;2年股骨柄翻修非骨水泥组4.4% vs 骨水泥组1.5%,柄并发症非骨水泥组2.0% vs 骨水泥组5.2%,放疗与手术方式均未独立关联柄并发症,骨水泥固定仍是所有患者的可靠选择。

要点

  • 2年股骨柄翻修累积发生率非骨水泥组4.4% vs 骨水泥组1.5%,因基线差异大未做统计学比较。
  • 2年柄并发症累积发生率非骨水泥组2.0% vs 骨水泥组5.2%,同样未做统计学比较。
  • 骨水泥组1例骨水泥植入综合征,非骨水泥组0例住院静脉血栓栓塞 vs 骨水泥组8例。

核心结论

  • 因研究组间基线差异大(反映仔细的患者选择),无法判断非骨水泥柄是否等同于或优于骨水泥柄。
  • 固定方式选择仍取决于患者年龄、骨质量、肿瘤组织学类型和病灶解剖位置等多因素。
  • 这些数据提示骨水泥固定仍是所有患者的可靠选择;对于经过良好选择的患者(一般<65岁、影像学近端股骨骨质量充足、所有肉眼可见病变被切除且有足够剩余骨接受非骨水泥固定),非骨水泥柄可成为合理选择,与放疗状态无关。

研究设计与样本

  • 2011年1月至2022年12月六中心回顾性研究,共337例因近端股骨转移性骨病行初次髋关节置换(全髋或半髋)。
  • 骨水泥组287例(全髋19%[55/287]、半髋81%[232/287]),非骨水泥组50例(全髋50%[25/50]、半髋50%[25/50])。
  • 骨水泥组66%(190/287)、非骨水泥组36%(18/50)患者在2年内死亡;骨水泥组21%(61/287)、非骨水泥组42%(21/50)患者在2年内失访但未知死亡。
  • 因固定组间基线差异大未做组间比较,分别以死亡为竞争风险报告累积发生率,并用逻辑回归评估放疗与固定方式是否独立关联柄并发症。

主要发现

  • 2年股骨柄翻修累积发生率(死亡为竞争风险)非骨水泥组4.4%(95%CI 0.8%–13.6%)vs 骨水泥组1.5%(95%CI 0.5%–3.5%)。
  • 2年柄并发症累积发生率非骨水泥组2.0%(95%CI 0.2%–9.4%)vs 骨水泥组5.2%(95%CI 3.0%–8.4%)。
  • 放疗患者中,2年股骨柄翻修累积发生率非骨水泥组0% vs 骨水泥组3.3%(95%CI 1.1%–7.8%),柄并发症非骨水泥组0% vs 骨水泥组7.8%(95%CI 3.8%–13.6%)。
  • 因假体周围骨折行股骨柄翻修的比例非骨水泥组2%(1/50)vs 骨水泥组2%(6/287)。
  • 住院期间静脉血栓栓塞非骨水泥组0% vs 骨水泥组2.8%(8/287);骨水泥组有1例骨水泥植入综合征。

关键数值与推荐

  • 股骨柄翻修定义为任何股骨再手术,包括股骨柄翻修、股骨柄取出伴或不伴间隔物、柄周围固定、因感染或脱位行头衬更换。
  • 柄并发症定义为无菌性松动、柄周围假体周围骨折、柄断裂或植入物骨折、或柄周围肿瘤复发;发生柄并发症不要求再手术。
  • 骨水泥固定多用于>65岁、影像学近端股骨骨质量较差、或病理性骨折和/或需病灶内切除而非完整切除的病灶。
  • 非骨水泥固定多用于<65岁、影像学近端股骨骨质量充足、且所有肉眼可见病变被切除并有足够剩余骨接受非骨水泥固定的病灶。
  • 排除行近端股骨切除及近端股骨置换的患者。

临床怎么用

  • 作者认为骨水泥固定仍是所有患者的可靠选择。
  • 作者认为对于经良好选择的患者(一般<65岁、影像学近端股骨骨质量充足、所有肉眼可见病变被切除且有足够剩余骨接受非骨水泥固定),非骨水泥柄可成为合理选择,与放疗状态无关。
  • 作者指出固定方式选择仍取决于患者年龄、骨质量、肿瘤组织学类型和病灶解剖位置等多因素。

局限性

  • 研究组间基线差异大(反映仔细的患者选择),无法判断非骨水泥柄是否等同于或优于骨水泥柄。
  • 骨水泥组66%(190/287)与非骨水泥组36%(18/50)患者在2年内死亡,骨水泥组21%(61/287)与非骨水泥组42%(21/50)患者在2年内失访但未知死亡。
  • 作者提出未来需开展比较性研究,聚焦于该亚组患者,以观察非骨水泥重建是否具有特定优势(如手术时间更短、骨水泥生理应激更少、骨整合机会)以及这些优势是否伴随重要权衡。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Hip arthroplasty is often indicated in metastatic bone lesions of the proximal femur, with or without pathologic fracture. Conventional knowledge is that cemented fixation is best, although uncemented fixation has potential advantages of shorter operative time, avoidance of the physiologic stress of cement, and the chance for osseointegration. However, both techniques are options that are employed, and there is no clear evidence to guide this choice. QUESTIONS/PURPOSES: In patients with proximal femoral metastatic bone lesions who were carefully selected either to receive cemented or uncemented fixation based on patient age, bone quality, tumor histology type, and the anatomic location of the lesion, we asked: (1) What is the cumulative incidence of femoral stem revision and stem complication in patients treated with cemented and uncemented hip arthroplasty for proximal femoral metastatic bone disease? (2) Are perioperative radiation and uncemented fixation independently associated with stem complication? METHODS: Between January 2011 and December 2022, six centers performed 337 primary hip arthroplasties (THA or hemiarthroplasty) for proximal femoral metastatic bone disease. While these relative indications for fixation technique varied by center and surgeon, cemented fixation was used in some centers exclusively; where used selectively, it was generally used more frequently in older patients (> 65 years), any patient with poorer radiographic proximal femoral bone quality, or in the setting of pathologic fractures and/or lesions requiring intralesional resection rather than complete resection. Uncemented fixation was often selectively used in younger patients (< 65 years) with adequate radiographic proximal femoral bone quality and often for lesions where all macroscopically visible disease was removed with sufficient remaining bone to accept uncemented fixation. A total of 287 cemented reconstructions (of which 19% [55 of 287] were THAs and 81% [232 of 287] were hemiarthroplasties) and 50 uncemented reconstructions (of which 50% [25 of 50] were THAs and 50% [25 of 50] were hemiarthroplasties) were performed. A total of 66% (190 of 287) and 36% (18 of 50) of patients, respectively, had died before 2 years, and 21% (61 of 287) and 42% (21 of 50), respectively, were lost to follow-up before 2 years but were not known to have died. As expected, the groups were substantially different at baseline, with the uncemented group being younger, less likely to have had a pathologic fracture, more likely to have received attempted wide resection rather than intralesional resection, more likely to have received this fixation technique at certain centers, and more likely to have received a THA, indicating a generally better preoperative functional status. Because of those substantial baseline differences between the fixation groups, we did not compare them but rather will report each separately in terms of survivorship with respect to stem revision and stem complication and factors associated with stem complication in this retrospective study. Those lost before 2 years were included if they reached a study endpoint before being lost. Patients who underwent a resection of the proximal femur and proximal femoral replacement were not included. Femoral stem revision was defined as any femoral reoperation including femoral stem revision, femoral stem explant with or without spacer, fixation around the stem, and head-liner exchange for infection or dislocation. A stem complication was defined as aseptic loosening, periprosthetic fracture around the stem, stem breakage or fracture of the implant, or tumor recurrence around the stem. A patient with a stem complication did not have to undergo a reoperation to be included. Competing risk analysis was performed to estimate cumulative incidence (95% confidence interval [95% CI]) of femoral stem revision and stem complication, with death as a competing risk. Logistic regression assessed whether radiation or uncemented fixation were independently associated with stem complication when controlling for each other. RESULTS: In all patients, the cumulative incidence (considering death as a competing risk) of femoral stem revision at 2 years in the uncemented group was 4.4% (95% CI 0.8% to 13.6%) and 1.5% (95% CI 0.5% to 3.5%) in the cemented group. The cumulative incidence of stem complication at 2 years in the uncemented group was 2.0% (95% CI 0.2% to 9.4%) and 5.2% (95% CI 3.0% to 8.4%) in the cemented group. In patients who received radiation, the cumulative incidence (considering death as a competing risk) of femoral stem revision at 2 years in the uncemented group was 0% and 3.3% (95% CI 1.1% to 7.8%) in the cemented group. The cumulative incidence of stem complication at 2 years in the uncemented group was 0% and 7.8% (95% CI 3.8% to 13.6%) in the cemented group. We did not compare the groups statistically because they were so dissimilar at baseline. The percentage of patients who underwent femoral stem revision for periprosthetic fracture in the uncemented group was 2% (1 of 50) and 2% (6 of 287) in the cemented group. The percentage of patients who developed an inpatient venous thromboembolism in the uncemented group was 0% and 2.8% (8 of 287) in the cemented group; there was one patient with bone cement implantation syndrome in the cemented group. When controlling for each other, radiation (OR 1.6 [95% CI 0.7 to 3.9]; p = 0.30) and uncemented fixation (OR 0.2 [95% CI 0.01 to 1.2]; p = 0.17) were not independently associated with stem complication. CONCLUSION: Because of substantial baseline differences between our study groups (which reflect careful patient selection), we cannot say whether uncemented stems are equivalent to or superior to cemented stems. Fixation choice remains multifactorial based on patient age, bone quality, tumor histology, and the anatomic location of the lesion. These data suggest that cemented fixation remains a reliable option for all patients. However, this study found that for well-selected patients-generally those who were younger (< 65 years) with adequate radiographic proximal femoral bone quality and with lesions where all macroscopically visible disease was removed with sufficient remaining bone to accept uncemented fixation-uncemented stems can be a reasonable choice regardless of radiation status. Future comparative studies should focus on that subgroup of patients to see whether there are any specific advantages to uncemented reconstruction, such as shorter operative time, less physiologic stress of cement, and the chance for osseointegration, and if there are, whether those advantages come with any important tradeoffs. LEVEL OF EVIDENCE: Level III, therapeutic study.

来源:Clin Orthop Relat Res,查看原文。版权归原作者所有。

引用

  1. Lawrenz JM, Chenard SW, Winter EP, et al. What Is the Cumulative Incidence of Femoral Stem Revision and Stem Complication in Cemented and Uncemented Hip Arthroplasty for Proximal Femoral Metastatic Bone Disease? Clin Orthop Relat Res. 2025. PMID: 40522275. doi:10.1097/CORR.0000000000003541

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。